AU6297294A - Adenosine deaminase inhibitor therapies - Google Patents

Adenosine deaminase inhibitor therapies

Info

Publication number
AU6297294A
AU6297294A AU62972/94A AU6297294A AU6297294A AU 6297294 A AU6297294 A AU 6297294A AU 62972/94 A AU62972/94 A AU 62972/94A AU 6297294 A AU6297294 A AU 6297294A AU 6297294 A AU6297294 A AU 6297294A
Authority
AU
Australia
Prior art keywords
adenosine deaminase
deaminase inhibitor
inhibitor therapies
therapies
adenosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62972/94A
Inventor
Mark David Erion
Gary Steven Firestein
Harry Edward Gruber
Mark Alan Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sicor Inc
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of AU6297294A publication Critical patent/AU6297294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62972/94A 1993-02-03 1994-02-02 Adenosine deaminase inhibitor therapies Abandoned AU6297294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1416093A 1993-02-03 1993-02-03
US014160 1993-02-03
PCT/US1994/001184 WO1994017809A1 (en) 1993-02-03 1994-02-02 Adenosine deaminase inhibitor therapies

Publications (1)

Publication Number Publication Date
AU6297294A true AU6297294A (en) 1994-08-29

Family

ID=21763871

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62972/94A Abandoned AU6297294A (en) 1993-02-03 1994-02-02 Adenosine deaminase inhibitor therapies

Country Status (3)

Country Link
AU (1) AU6297294A (en)
IL (1) IL108522A0 (en)
WO (1) WO1994017809A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108524A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Imidazodiazepine analogs
US5366960A (en) * 1993-08-26 1994-11-22 Warner-Lambert Company Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol
EP0871449A1 (en) * 1996-02-12 1998-10-21 Cypros Pharmaceutical Corporation Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits
IL121272A (en) * 1997-07-10 2000-06-01 Can Fite Technologies Ltd Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
US6103702A (en) * 1999-05-24 2000-08-15 Board Of Trustees Of The University Of Illinois Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
AU6234000A (en) * 1999-07-22 2001-02-13 Supergen, Inc. Methods for treating autoimmune diseases
CN113995833B (en) * 2021-11-10 2023-12-26 南京南方元生物科技有限公司 Adenosine deaminase and application of modification thereof in preparation of diabetes wound repair drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673563A (en) * 1980-10-14 1987-06-16 The University Of Virginia Alumni Patents Foundation Adenosine in the treatment of supraventricular tachycardia
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance
US5231086A (en) * 1985-09-24 1993-07-27 Item Development Aktiebolag Continuous administration adenosine to increase myocardial blood flow
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
WO1994017809A1 (en) 1994-08-18
IL108522A0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
AU6236594A (en) Adenosine kinase inhibitors
AU5319194A (en) Parallel computer system
AU5533094A (en) Enzyme inhibitors
EP0649087A3 (en) Computer system
AU7190094A (en) Electrofilter
AU7594594A (en) Slip-correcting load-clamping system
AU6383494A (en) Localising system
AU7760994A (en) Block wall system
AU4772493A (en) Sulfo-derivatives of adenosine
AU6550694A (en) Multiple computer system
EP1475699B8 (en) Multiplier
AU6090594A (en) Angiotensin ii inhibitors
AU6519294A (en) Screwdriver
AU6941594A (en) Sound-to-light graphics system
AU6117794A (en) Optimal article grading system
AU6297294A (en) Adenosine deaminase inhibitor therapies
AU5798394A (en) Thiadiazinones
AU6224194A (en) Blast-cleaning system
AU1119495A (en) Game system
AU1274295A (en) Heteroarylpyrroles
AU5118493A (en) Aromatase inhibitor
AU2546195A (en) Adenosine derivatives
AU1114995A (en) Checking of winning combinations
AU5156793A (en) Eosinophil infiltration inhibitor
AU7269394A (en) Umbilical structures